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Summary 
Background: A too low or a too high birth weight has been linked to adverse health risks 
in both a short and long term perspective. In Norway the prevalence of macrosomic infants 
(>4000g and 4500g) has increased in the last years. Identifying factors that affect birth 
weight: are of crucial interest in order to prevent problems pertaining to infants that are 
born too large. In this study maternal energy intake, energy-adjusted intake of 
macronutrients and intake of fiber, were examined to identify possible associations with 
birth weight. Maternal diet was also described.                                  
Design: Cohort study              
Setting: Dept. of Obstetrics and Gynecology, Rikshospitalet-Radiumhospitalet Medical 
Centre, Oslo, Norway.           
Subjects: A total of 553 pregnant women and their infants. The subjects were followed 
through pregnancy and delivery during the period of 2002-2005.       
Methods: The pregnant women's dietary intake during both the second and third trimester 
of pregnancy was ascertained in gestational week 14-16 and 30-32 by using a food 
frequency questionnaire.             
Results: A large proportion of the pregnant women had intakes of macronutrients and 
fiber that were not within the recommended ranges: 66% had too low intake of fiber, 30% 
too much added sugar, 85% too much saturated fat and 42% too little intake of omega-3 
fatty acids in week 14-16. This trend shows a significant deterioration as the pregnant 
women proceed from the second to week 30-32: they eat more saturated fat, more added 
sugar and less fiber. High intake of protein in week 14-16 is associated with reduced risk 
of giving birth to a macrosomic infant (OR=0,5). In univariate analyses, intake of added 
sugar and omega-3 fatty acids was associated with birth weight.                        
Conclusion: High intakes of protein have a significant preventive effect on the risk of 
delivering a macrosomic infant. However, the effects of high protein diets during 
pregnancy have shown adverse health effects, and should not be promoted. Many 
pregnant women eat an unbalanced diet, not within the recommended guidelines. Much 
can possibly be achieved by promoting the already existing recommendations. Especially 
inactive and overweight pregnant women should be paid special attention.  
__________________________________________________________________________ 
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Sammendrag 
Bakgrunn: En for lav eller for høy fødselsvekt har blitt knyttet opp mot økt risiko for 
ugunstig helse, både på lang og kort sikt i forhold til barn som er normalvektige ved fødsel. 
I Norge har prevalensen av makrosomiske barn (>4000g and 4500g) økt over de siste 
årene. På grunn av denne uheldige utviklingen med for mange store barn, er det av stor 
interesse å avdekke hvilke faktorer som påvirker fødselsvekten. I denne studien ble mors 
energiinntak, energijustert inntak av makronæringsstoffer samt inntak av fiber undersøkt 
for å finne mulige sammenhenger med fødselsvekt. Mødrenes kosthold ble også 
beskrevet.                  
Design: Kohort                   
Sted: Avdeling for Obstetrikk og Gynekologi, Rikshospitalet-Radiumhospitalet Medisinsk 
senter, Oslo, Norge i tidsperioden 2002-2005.         
Studieobjekter: Totalt 553 gravide kvinner og deres barn. Mødrene ble fulgt gjennom 
svangerskapet og fødsel.                  
Metode: De gravide kvinnenes matinntak ble registrert både i tidlig andre trimester (uke 
14-16) og sent i tredje trimester (uke 30-32) ved bruk av FFQ (matfrekvensspørreskjema). 
Resultater: En stor andel av kvinnene i "Store barn og komplikasjoner” (STORK) hadde et 
inntak av makronæringsstoffer og fiber som ikke lå innenfor de anbefalte grenser: 
følgende hadde 66% for lavt fiberinntak, 30% for høyt sukkerinntak, 85% for høyt mettet 
fettinntak og 42% for lavt inntak av omega-3 fettsyrer i andre trimester. Denne negative 
trend ble ytterligere forverret når kvinnene går fra uke 14-16 til uke 30-32 i svangerskapet: 
de spiser mer mettet fett, mer tilsatt sukker og mindre fiber. Et høyt inntak av protein i uke 
14-16 er assosiert med en redusert risiko for å føde et makrosomisk barn (OR=0,5). 
Sukkerinntaket og inntak av omega-3 fettsyrer var assosiert med fødselsvekt i 
univariatanalyser.                   
Konklusjon: Et høyt inntak av protein i gravides kost gir en signifikant lavere risiko for å 
føde et makrosomisk barn. Imidlertid har høyproteindietter under graviditeten vist å kunne 
ha en skadelig effekt og bør derfor ikke anbefales. Mange gravide spiser en ubalansert 
kost, som ikke er i overensstemmelse med de anbefalte retningslinjer. Mye kan 
sannsynligvis oppnås ved å promotere de allerede eksisterende anbefalinger, og spesielt 
inaktive og overvektige gravide bør få spesiell oppfølging. 
__________________________________________________________________________ 
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1. Introduction 
This study is a part of a cohort: 'The increasing prevalence of fetal macrosomia: A 
prospective study including endocrinological, metabolic, placental and nutritional 
characteristics of pregnant women who give birth to macrosomic infants'. The Norwegian 
name of the project is STORK (Store barn og komplikasjoner). The purpose of STORK is 
to establish better methods for identifying at-risk pregnancies so that intervention studies 
and/or appropriate management strategies can be improved in order to reduce: 
a) Pregnancy and delivery complications (short term outcomes) 
b) Long term health risks for the mother and her child (long term outcomes) 
STORK is carried out in two turns: STORK 1 and STORK 2. A total of 1200 pregnant 
women are followed longitudinally through their pregnancy from week 14-16 until the first 
week post partum. 
One of the main aims of STORK is to examine different determinants of intrauterine 
growth. The predictors of development concerning overweight and obesity in the fetus are 
of special interest.  
In this study I am interested in exploring the nutritional determinants. Other factors have 
not been examined, and I have analysed data from STORK 1 exclusively, as STORK 2 
data were not yet collected when the analyses were conducted.   
Three PhD-students are using data from the STORK-project in their thesis, one of which is 
Nanna Voldner. In the thesis 'Maternal metabolic syndrome, fetal macrosomia and 
pregnancy complications', Voldner assesses several variables including dietary data and 
possible correlations to the clinical outcomes. This study is a part of her PhD-work. Voldner 
has assessed the effect the mean dietary intake of energy, fat, protein and carbohydrates 
during pregnancy has on the risk of delivering a macrosomic baby (birth weight >4200 g). 
However, Voldner has not examined whether the effects are more pronounced in early or 
late pregnancy, or if there are effects of dietary factors other than the ones mentioned. In 
addition, Voldner has not described the diet of the STORK population in detail, which is of 
great interest due to the scarcity of other studies of diet in the Norwegian pregnant 
population. 
 
__________________________________________________________________________ 
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Consequently, I wanted to assess the effect of the dietary factors in both early and late 
pregnancy, not only the mean effect during pregnancy upon birth weight and the risk of 
infant macrosomia. I have analysed dietary data in second and third trimester of 
pregnancy separately, and I have included more nutritional variables than Voldner by 
fractioning the fatty acids and carbohydrates into different components. Finally, I have 
carried out a detailed descriptive dietary analysis of the diet of the pregnant women in the 
STORK project. 
__________________________________________________________________________ 
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2.  Background 
Birth weight and fetal growth are decisive factors when it comes to the health outcomes for 
infant and mother, and are therefore of interest in preventive and clinical medicine. Both 
Genetics and the intrauterine environment provided by the mother are determinants of 
birth weight. This intrauterine environment may be affected by several factors including the 
maternal prepregnant weight, weight gain during pregnancy and physical fitness. Maternal 
nutrition during pregnancy is also a part of this environment, but may furthermore affect 
fetal genes through genetic imprinting (1-4).  
Natural history cohorts, especially the one surrounding the Dutch famine of 1944–1945, 
have given researchers a unique way of studying the effect of nutritional deprivation during 
different stages of pregnancy and health outcomes for the infant (5). New studies are 
continuously adding updated information to the body of evidence concerning which factors 
affect birth weight, growth and perinatal health. 
2.1. Present recommendations during pregnancy 
2.1.1. Dietary recommendations during pregnancy; levels of  macro- and 
micronutrients 
According to the Nordic Nutritional Recommendations from 2004 (NNR 2004) (6), pregnant 
women are supposed to eat a balanced healthy diet in sufficient amounts, that in most 
respects is similar to what is recommended for the population at large. There are only a 
few exceptions from the general recommendations. 
Energy needs 
Pregnant women are thought to have extra energy needs due to fetal growth, and 
endogenous tissue growth consisting of blood, extra-cellular water, uterus, breasts, body 
fat and placenta. It is estimated that an average extra intake of 1.1 mega joule (MJ)/day 
during pregnancy is sufficient to meet these needs (6). A meal consisting of one slice of 
bread (30 g), margarine (5 g), ham (15 g), one apple (155 g) and one glass of semi-
skimmed-milk (1.5 dl) gives approximately 1.1 MJ (260 kcal) (7). More specifically, the 
extra energy requirements seem to be negligible in the first trimester of pregnancy, 
__________________________________________________________________________ 
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increased to 1.5 MJ/day in week 14-16 and as large as 2.1 MJ/day in week 30-32 of 
pregnancy. In addition, it is believed that many women compensate for their increasing 
energy needs by decreasing their level of activity, reducing the extra energy needed to 
less than 2.1 MJ extra per day (6). 
Essential fatty acids 
Essential fatty acids are the polyunsaturated fatty acids (PUFA) consisting of omega-6 and 
omega-3 fatty acids - that cannot be synthesized in the human body, and consequently 
must be provided through food intake. On the macronutrient level, the recommended 
intake of essential fatty acids should be higher among pregnant women than among the 
general population. The contribution of PUFA should contribute a minimum of 5% of the 
total energy intake (E%), including at least 1 E% from omega 3-fatty acids (6). 
Micronutrients 
During pregnancy there is an increase in the need of micronutrients. Supplement of folic 
acid (400 µg/day) is recommended from one month before conception, and through the 
first trimester for all pregnant women and women planning a pregnancy. Iron 
supplementation is recommended to pregnant women with anemia (Hb<10,5 g/dl), and for 
those who cannot cover their iron requirements through diet alone (i.e. vegans). Low Hb 
values (between 8,5 g/dl and 10,5 g/dl) are, however, associated with a lowered risk of low 
birth weight and premature birth, whereas even lower and very high levels are associated 
with a higher risk (8). Vitamin A intake must be kept close to the recommended levels of 
800 µg/day, because both retinol deficiency and retinol excess may give fetal 
malformations (6). An intake of 10 µg/day of vitamin D is recommended during pregnancy 
to ensure optimal levels in both mother and fetus. Adaptation to calcium absorption is very 
efficient during pregnancy, but the recommended intake is still higher (900 mg/day) than 
what is recommended to non-pregnant women. 
2.1.2. Prepregnant body weight 
Maternal prepregnant weight or BMI (body weight in kg/height in meters2) are positively 
correlated with infant birth weight, and is strongly associated with perinatal health (9-18). 
Maternal prepregnant underweight is associated with giving birth to infants born small for 
gestational age (SGA), defined in chapter 2.3.1, spontaneous preterm delivery and 
maternal delivery complications (11;13;14). On the contrary, maternal prepregnant 
overweight and obesity protects against delivery of SGA infants, but increases the risk of 
__________________________________________________________________________ 
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stillbirth and neonatal death (10;12). In addition, maternal obesity is associated with 
preeclampsia, gestational diabetes mellitus, hypertension and cardiovascular disease, 
increased risk of miscarriage, caesarean deliveries, shoulder dystocia, postoperative 
complications, low Apgar score, neural tube defects and macrosomia (10;15-18).  
This data indicates that the optimal maternal prepregnant BMI and weight should be within 
the normal range, defined by the World Health Organization (WHO) as a BMI of 18.5-24.9 
kg/m2 (19). Norwegian guidelines recommend that under- or overweight pregnant women 
should receive individual advice on diet and physical activity, in addition to the standard 
follow up in health institutions (8). New, updated Norwegian guidelines will soon be 
published, but are not yet available to the public (20). 
2.1.3. Weight gain during pregnancy 
Maternal weight gain during pregnancy is related to the infant's birth weight (21;22). A 
large weight gain during pregnancy is a strong predictor of delivering large for gestational 
age (LGA) and/or macrosomic infants (23). Yet, there are no clear recommended levels of 
weight gain during pregnancy in Norway, nor are there reliable data on weight gain during 
pregnancy in the Norwegian population. However, health workers are advised to weigh the 
pregnant women early, at week 8-12, and later routinely weighing them as practise through 
the pregnancy (8).  
 
Despite of the lack of established recommendations, the American Institute of Medicine's 
guidelines (IOM) (24) on weight gain during pregnancy are suggested as a guide to health 
workers (8). These guidelines are based on the maternal BMI in the prepregnant state. 
Thus, the recommended weight gain is different for women with low weight (BMI<19.8 
kg/m2), normal weight (BMI 19.8-26 kg/m2) and high weight (BMI 26.1-29.0 kg/m2). These 
weight cut-offs are defined by the IOM (24) and differ slightly from the WHO cut-off values 
(19). For women within the normal weight range a weight gain between 11.5-16 kg seems 
to be optimal. Women within the lower weight ranges can gain up to 18 kg while obese 
women should ideally limit their weight gain to 6 kg, but not less. The recommendations 
are based on observational studies, and the recommended ranges are associated with the 
best outcome for both mothers and infants (24;25). However, American studies have 
shown that few pregnant women follow these guidelines (25). 
__________________________________________________________________________ 
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2.1.4. Physical activity in pregnancy 
When it comes to the impact of exercise during pregnancy on birth weight, there exist few 
studies and the findings are not consistent (26;27). However, an American study of 51 
pregnant women from 2007 showed that aerobic physical activity was strongly and 
inversely associated with fetal growth, especially among taller women. Accordingly, aerobic 
physical activity in pregnancy may be an important determinant of birth weight within the 
normal levels (28).  
Up until resent years it was not known whether physical activity during pregnancy was 
harmful for the fetus. However, new evidence has accumulated and shown that moderate 
physical activity during an uncomplicated pregnancy has no harmful effects (29;30). In a 
Norwegian study of 42 women it was shown that healthy and well-trained pregnant women 
may perform high intensity exercise during their pregnancy without compromising fetal 
growth and development (29). 
In total, physical activity during pregnancy appears safe and seems to contribute to various 
health benefits: better maternal fitness, better sense of well-being, reduced physical 
discomfort during pregnancy and reduced risk of contracting gestational diabetes and 
preeclampsia (31-33). 
The recommendations from The American College of Obstetricians and Gynecologists, 
state that in the absence of either medical or obstetric complications, 30 minutes or more 
of moderate exercise a day on most, if not all, days of the week is recommended for 
pregnant women. Extreme sports activities and activities with high risk of abdominal 
trauma should be avoided (30). The Nordic recommendations from 2004 (6) are generally 
based on the same scientific evidence as those from The American College of 
Obstetricians and Gynecologists, and are consequently fairly similar.   
       
In a Norwegian study an assessment of the physical activity level during pregnancy and its 
association with maternal weight gain during pregnancy was conducted. All study subjects 
were drawn from the STORK population. Consequently, the results showed that among 
the pregnant women from the STORK population a high percentage of women exceeded 
the recommended weight gain, as well as having a low physical exercise level (34).  
      
__________________________________________________________________________ 
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2.2. Epigenetics: nutrient–gene interactions 
Epigenetic changes are understood as the hereditary changes in gene expression that are 
not mediated by DNA sequence alterations (35). Instead of changing in the DNA 
sequence, genes are activated or silenced. The chromatin structure affects how the DNA 
is packed and organized in the cell nucleus, and is decisive for the availability of 
transcription of the genes. There seems to be a variety of possible factors that may affect 
the structure of the chromatin, such as methylation, acetylation and 
treonine/serinephosphorylation (36).  
Accumulating evidence indicates that nutrients can influence the degree of methylation 
and demethylation of genes, and thus induce permanent changes in gene expression, 
which may affect the fetus during critical periods of its development. Instances of how diet 
may affect the expression of genes, and hence ultimately the genotype, have been shown 
in several experiments, including in by Wolff et al. In their study genetically identically 
pregnant inbred Avy/a mice were fed different diets, hence different levels of methyl 
supplementation. The results showed that their offspring obtained different fur-color 
according to the diet they had been exposed to, ranging from brown to yellowish (37).  
2.3.  Birth weight 
2.3.1. Infants born SGA 
Infants who are 'small for gestational age' (SGA) have a birth weight far below the mean 
values for their gestational age when compared to an appropriate reference population 
(gender, ethnicity and geographic area). The most used cut-off points are birth weight 
below the 10th percentile and 2 SDs below the mean for gestational age. In variation, the 
2.5th or 5th percentile, or 3 SDs below the mean are used (38). The prevalence of infants 
born SGA depends on how this level is defined. 
Different levels of low birth weight are often defined as: Low birth weight (LBW <2500 g), 
Very low birth weight (VLBW <1500 g) and Extreme low birth weight (ELBW <1000 g). In 
Norway in 2006 the prevalence of infants weighing less than 2500 g at birth was 6.6% 
(39). 
__________________________________________________________________________ 
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2.3.2. Infants born macrosomic 
No consensus exists when defining excessive birth weight. Born large for gestational age 
(LGA) has been defined in several different ways in different studies. The various 
definitions are: above the 90th percentile, or 2 SDs above the mean for the given 
gestational age in the reference population (40;41). Fetal macrosomia is normally 
expressed in absolute weight, with a defined cut-off weight. However, different cut-off 
levels flourish. Levels of ≥4000 g (grade 1), ≥4500 g (grade 2) or o ≥5000 g (grade 3) are 
used (42-44). 
The prevalence of infants weighing more than 4000 g at birth in Norway in 2006 was 
18.9%, 3.6% weighed more than 4500 g and 0.3% weighed more than 5000 g (39).  
2.3.3. Optimal birth weight 
When looking at high or low birth weights and their respective consequences, both are 
associated with increased mortality. A reversed J-shaped curve, or a U-formed curve is 
found, indicating a marked decrease in total-mortality risk and morbidity from the lowest 
birth weights up to average birth weights and then an increase towards the highest birth 
weights (45-47). 
 
Nevertheless, there is no consensus of what the optimal birth weight for an infant is. When 
using perinatal mortality rates to locate the optimum weight, differences between different 
populations generate some difficulties. An epidemiological study from 2002 showed that 
there are significant area-specific variations in birth weight distribution and in the birth 
weight associated with the lowest perinatal mortality (48). The minimal perinatal mortality 
risk varied considerably: 3755 g in Flanders and 4305 g in Norway (48). In a Japanese 
study from 2006, the lowest perinatal mortality rate in singleton pregnancies was found for 
birth weight in between 3.5-4.0 kg (49). 
There is not sufficient evidence for any firm conclusions on what is the exact optimal birth 
weight. Yet, when looking at perinatal mortality and total-mortality and morbidity, it is likely 
that an infant's optimal birth weight should be somewhere between all extreme values.  
__________________________________________________________________________ 
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2.4. Developmental origins of adult health and disease/ 
Barker's hypothesis 
Nutritional conditions during fetal development are strongly associated with health 
parameters in the individual, both with regards to short and long term consequences (1;2). 
This area of research is of interest because of its potential usefulness in both clinical and 
preventive medicine in the future. The general hypothesis claims that the fetal 
environment, including nutritional conditions, gives rise to epigenetic changes which may 
permanently affect the metabolism, structure and physiology in the fetus' future life in a 
manner that may increase or decrease the susceptibility to disease (3). A widely used term 
is 'fetal programming'. The term 'developmental origins of adult health and disease' that 
includes environmental programming in early postnatal life has been introduced based on 
'fetal programming'.  Both epidemiological and experimental studies support the 
hypothesis underlying developmental origins of health and disease (1;2;50;51). The 
International Society for Developmental Origins of Health and Disease (DOHaD) has been 
established to promote research within this field. 
Most studies examine the health consequences that occur later in life when the child is 
born SGA. The main findings in these studies show that nutritional deprivation during fetal 
life often result in a low birth weight, which is associated with increased risk of diabetes, 
high blood pressure and coronary artery disease later in life (1;2).  
Studies of being born LGA or macrosomic have only in recent years flourished as an area 
of research (4;52-56). It is now evident that giving birth to a macrosomic infant, or being 
born as one, is associated with a number of health risks. In a short term perspective there 
is an increased risk of complications during pregnancy and delivery, such as intrauterine 
death, artificial induction of labour, prolonged birth, birth asphyxia, injuries to the infant and 
the mother, increased use of instrumental vaginal deliveries and delivery by caesarean 
section. In addition, the mother has an increased risk of experiencing post partum 
haemorrhages, and the infant is more likely to develop neonatal hypoglycaemia and 
hyperbilirubinemia. Macrosomic infants need neonatal intensive care more often compared 
with normal-weight-infants (4;17;57-60).  
Being born macrosomic is also associated with long-term adverse health effects in the 
individual. There is an increased risk of neurological sequels, adiposity, diabetes and 
cancer (4;55;56;61-63). It has been suggested that nutritional and metabolic imbalances 
__________________________________________________________________________ 
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during fetal life are the contributing factors in a marked increase (33%) in childhood 
obesity and type 2 diabetes that has been in the United States from 1990 to 1998 (53).  
In the past decades the mean birth weight and the percentage of new-borns with a birth 
weight >4000 g has increased in the Nordic countries, and as a consequence there has 
been an increase in the prevalence of macrosomic infants. New-borns in Norway weighing 
more than 4000 g has risen from 16% in 1990 to 22% in 2000 (64;65). There has been a 
minor decrease in mean birth weight in Norway since 2000, and the percentage of infants 
weighing 4000 g or more was 19.6% and 18.9% in 2005 and 2006, respectively (39). This 
may be explained by changes in the clinical approach. An increased focus on the 
macrosomic infants may have led to earlier induced labour and cesarean sections to 
ensure that the infants are born before they become too large. 
Despite the minor change in recent years, the prevalence of macrosomic new-borns is still 
high and a source of great concern. Therefore, the factors influencing the nutritional status 
of the fetuses need to be assessed. Knowledge gained from this study may be essential 
both in clinical and preventive medicine.  
2.5. Aims and definitions 
2.5.1. Purpose of study 
We know: 
1. Earlier dietary surveys from the 1990'es have revealed inadequate dietary patterns 
in a population of urban, Norwegian pregnant women (66;67). Hence, descriptive studies 
of this group are important in order to see if dietary habits have changed.  
2. The prevalence of fetal macrosomia is high in Norway (39). Since we already have 
gained an understanding of the adverse health outcomes associated with a high birth 
weight, it is important to identify contributing factors. Diet, body weight and fitness, in 
addition to weight gain during pregnancy, are modifiable factors. If a more certain 
relationship between these modifiable factors and the risk of macrosomia could be 
established, it will be easier to offer advice to pregnant women on how to achieve a 
healthier lifestyle and thus prevent adverse health outcomes. 
 
 
__________________________________________________________________________ 
_____________________________________________________________________ 
27
The purpose of this thesis is therefore: 
To describe the population of pregnant women and their dietary habits (aim 1); To find and 
describe whether or not maternal modifiable factors, especially dietary ones, contribute to 
a higher birth weight or higher risk of macrosomia (aim 2). Furthermore, by reviewing the 
literature and own findings I will attempt to evaluate whether or not the recommendations 
given to pregnant women on modifiable life style factors today: maternal diet, physical 
activity and weight gain, overweight and/or obesity, during pregnancy - are the optimal 
when the goal is to reduce the risk of macrosomia. 
  
2.5.2. Aims 
The specific aims are described in the following section: 
1. To describe the characteristics of the STORK population and investigate 
their dietary patterns during pregnancy. 
a. To find whether or not women giving birth to a macrosomic infant can be 
described by specific characteristics. 
b. To investigate whether or not the dietary intakes differ between early 
and late pregnancy. 
c. To investigate whether or not the nutrient intake among the pregnant 
women are within the recommended levels. 
d. To investigate what food items contribute most to energy-intake, energy-
providing nutrients and fiber in the maternal diet. 
e. To investigate the degree to which the mixed greens intake among 
pregnant women are within the recommended levels. 
   
2. To investigate to what degree and how consumption of nutrients in early 
and late pregnancy affects the infant's birth weight or contributes to a 
higher risk of macrosomia. 
 
a. To investigate to what degree and how eating an 'obesogenic diet'* 
during pregnancy affect the infant's birth weight. 
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b. To investigate to what degree different levels of energy, energy-
providing nutrients and fiber intake during pregnancy affects the infant's 
birth weight. The different levels of nutrient intake are: high, low and 
different quartiles. 
 
c. To investigate to what degree eating an 'obesogenic diet'* during 
pregnancy contribute to a higher risk of macrosomia. 
 
d. To investigate to what degree different levels of energy, energy-
providing nutrients and fiber intake during pregnancy affects the risk of 
delivering a macrosomic infant. The different levels of nutrient intake 
are: high, low and different quartiles. 
 
*'Obeseogenic diet'= see section: ’2.5.3. Definitions’ 
2.5.3. Definitions 
Macrosomic infant 
Infant weighing ≥4200 g at birth is defined as macrosomic in the STORK project. This level 
was chosen because in a clinical perspective a birth weight ≥ 4200 g seems to be a cut-
off-point at which the risk of where delivery-complications are notably high (20). In addition, 
the 4200 g level corresponds to the 90th percentile of birth weight in Norway. 
Obesogenic diet 
High total energy 
When dividing the subjects into categories of high and lower energy intakes, their self-
reported energy intakes were subtracted from their estimated energy needs before being 
grouped. Ideally, their actual energy needs (physical activity level (PAL) and Basal 
Metabolic Rate (BMR)) should be used to see who ate in excess of their actual energy 
requirements. However, PAL- levels were not available. BMR was calculated using Harris-
Benedict's equation for every individual in order to reach the best possible estimate. 
Because the equation seems to overestimate the BMR with 5-13% among women (68), 
the PAL was set somewhat lower than what would be expected for pregnant women 
(69;70) to compensate and not to overestimate. Finally an average PAL-level of 1.3 was 
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set. Consequently, women in the 4th quartile when calculating 'Reported energy intake'- 
'Estimated energy requirements' (most positive energy-balance) were considered as 
subjects having a high-energy intake.  
Low dietary fiber 
An intake of <25 g per day OR <3 g/MJ is considered a low level. 
High added sugars 
Added sugars include sucrose (table sugar) and fructose. A high level is considered a level 
>10 E%. 
High fat 
A diet with >30 E% from total intake of fatty acids, including saturated, monounsaturated 
and omega-3 and omega-6 fatty acids is considered a high intake. 
Low protein 
A level <15 E% from dietary protein is considered a low intake. 
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3. Subjects and Methods 
3.1. Study design and inclusion 
This prospective study with a cohort design was conducted in Oslo, the capital of Norway. 
A total of 588 healthy pregnant women of Scandinavian heritage were recruited from the 
Rikshospitalet-Radiumhospitalet Medical Centre between the year of 2002 and 2005.  
Figure 1. Included subjects in STORK 
 
Women with multiple pregnancies or with known severe diseases including diabetes 
mellitus type 1, lung, kidney, gastrointestinal or cardiac disease, were excluded. There 
were 35 recruited women lost to follow up of various reasons. Eight were excluded 
because of suspected fetal malformations and 6 expected more than one infant. Two 
intrauterine deaths occurred at term, one with unexplained cause and the other caused by 
the mother developing an acute fatty liver. Nineteen additional women were lost from other 
reasons including giving birth at another hospital, moving out of the area or retired from a 
Invited
2145
Not accepted invitation 1467
Accepted 
invitation
678
Withdrew 90
Included at start o f 
study
588
Lost 35
Followed  up
553
Stillborn 2
Malformations 8
Twins 6
Delivered at other
hospital/moved out of 
area 11
Unknown 8
Withdrew 90
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continued participation. Thus a total of 553 mother and infant-pairs formed our study 
group.   
3.2. Data collection 
3.2.1. Anthropometrical measures 
All women included were followed up 4 times during the pregnancy. At visit 1 (week 14-16 
of gestation) height and weight were obtained. Height was measured to the nearest 
centimetre if not reported by the person. Weight was measured to the nearest 100-gram 
on a digital scale with subjects dressed in light clothes and without their shoes on.  
The newborn infants were weighed to the nearest 10-gram on a digital scale (Data Baby-
Scales 930 from SOLOTOP OY, Finland) after delivery, no later than two hours after birth. 
Date for the delivery of the infant (gestational age) was decided at the routine ultrasound 
of the fetus in week 17-19, and was collected from the hospital journals. 
During the time of collecting data, a change from manual to digital databases was done at 
the delivery unit, thus data from the first 150 deliveries were collected from paper journals 
and the latter from the new digital database (Obsterix, from Siemens).     
Additional measurements and samples were conducted and taken both of mother and 
fetus during the study period, but are not discussed in further detail as they are not 
investigated in this thesis. 
3.2.2. Dietary assessment 
NORKOST 
A self-administered Food Frequency Questionnaire (FFQ), NORKOST 1997 (see 
Appendix) was used to measure the subjects' dietary habits twice during pregnancy: week 
14-16 and 30-32. Out of the 553 pregnant women in the study, 5 did not return the first 
FFQ from week 14-16, and 42 did not return the second FFQ from week 30-32. Thus we 
have dietary data from 548 women early in the second trimester (week 14-16) of 
pregnancy and from 511 women relatively late in the third trimester (week 30-32). 
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Table 1. Total of missing FFQs in the study. Study subjects reported their food intake twice.  
 
The FFQ is designed to measure the mean intake the last six months or last year. It 
consists of questions about how often and how much is eaten of certain foods, drinks and 
dishes. Approximately one-hundred-and-eighty food groups are found in the questionnaire.  
In STORK, subjects were to report what they usually ate at the time they completed the 
questionnaires. Written instructions on how to fill out the questionnaire was found on the 
first pages (see Appendix). Unless subjects specifically asked for it, no other instructions 
were given.     
Nutrition calculation database  
The completed FFQs were computer-scanned, and manually checked for errors, using 
Teleform 6.0. The same person conducted the scanning and verifying. The Database IE96 
for nutrient calculations, developed at The Institute for Nutrition Research, University of 
Oslo, Norway, was used to calculate the food intake and the nutrient content of the 
participants' reported food intake. The database is based on the Food table from 1995 
(71). Dietary supplements are included in the calculations (cod liver oil, multivitamin-
mineral-supplements, vitamin B-, C-, D-, and E- supplements, iron, calcium and fluoride). 
In the newest version of the Food table from 2006, online publication (72), fiber is 
reckoned as a energy giving nutrient, contributing with 8 kJ/gram, in contrary to the 1995-
version which the analyses in this thesis are based upon. 
3.4. Statistics 
All analyses are conducted using The Statistical Package of Social Sciences (SPSS, Inc., 
Chicago, IL, USA) version 14.0. The level of statistical significance was set at the 0.05-
level, thus any p-value at this level or lower was considered a significant result.  
All Participants Returned FFQs week 14-16 of pregnancy Returned FFQs week 30-32 of pregnancy
N=553 N=548 N=511
5 missing 42 missing
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3.4.1. Descriptive statistics 
Subject characteristics 
Differences between mean in groups were compared with T-test. The non-parametric 
alternative Mann Whitney was used to compare groups when the data in the groups were 
not normally distributed. Chi-square test was used to look at differences in the 
dichotomous characteristics. Fisher's test was used as an alternative when the 
assumptions of the Chi-square test were not met. 
Diet and food characteristics 
a) Possible alterations in dietary variables between early and late pregnancy were 
examined by using the paired sample T-test (2-tailed) and the non-parametric alternative 
Wilcoxon Signed Rank test. 
b) The Database IE96 was used to calculate the amount consumed of different food-types 
and what food items contributed to the energy giving nutrients, energy and fiber.  
3.4.2. Analysis of correlation 
Pearson's correlation analysis was conducted to look at patterns between the nutrition 
factors from both the second and third trimester and the infant's birth weight. To check if 
the assumptions of normal distribution, linearity and homoscedasticity were violated, I 
looked at the shape of the scatterplots and the descriptive statistics. Spearman's 
correlation analysis was used when the assumptions of Pearson's analysis were violated.  
3.4.3. Comparing groups 
Obesogenic diet versus non-Obesogenic diet 
Women eating an 'Obesogenic diet' were compared to women eating within the 
recommended levels in the New Nordic Recommendations 2004 (6). If a subject fulfilled 
one or more of the defined criteria she was defined as eating an obesogenic diet. 
Groups were tested to see if they were both coming from a normally distributed sample.  T-
test was used when the dietary variables met this assumption of normality; otherwise the 
non-parametric test Mann-Whitney was conducted. 
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Quartiles 
The Kolmogorov-Smirnof-test-of-Normality and histograms were used to see if the infants' 
birth weight were normal distributed within each group (quartile). When so, the One-Way-
Anova was used to test if there was a significant difference in mean birth weight between 
these groups. The Bonferroni test is used in the post-hoc-testing. The non-parametric 
alternative was the Kruskal-Wallis Test. 
Low versus high levels 
Bionomic variables were constructed from the food-variables, to see if women in the 4th 
quartile of energy/macronutrients/fiber intake gave birth to infants weighing more or less 
than women with lower intakes. The 4th quartile group and the lower intake group were 
tested to see if they were both normally distributed, and an Independent-samples-T-test 
was conducted when assumptions were met. The non-parametric alternative was the 
Mann-Whitney test.  
3.4.4. Regression 
Univariate analyses 
Univariate analyses were conducted prior to the multivariate analyses. Birth weight of 
infants was the dependent continuous variable, measured in grams. The different 
independent variables were dietary factors and subject characteristics. The dietary 
variables in this study are assumed to have a non-linear relationship with birth weight, in a 
similar manner as the U-formed relationship between Body Mass Index and morbidity and 
mortality (73). Thus dummy variables were created using quartiles, to avoid this possible 
problem with non-linearity. Categorical variables with more than two categories were also 
included in the model as dummy variables.  
Linear multiple regression 
Two different models were created. One included subject characteristics and dietary 
factors from week 14-16 of pregnancy, the other included dietary variables from week 30-
32 in addition to subject factors.  
Birth weight was the dependent variable as in the univariate analyses. Independent 
variables were included in the models based on knowledge from former research on 
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contributing factors to birth weight, or if they were significant in the univariate analyses at 
the 0.10 level and significant in the complete model at the 0.05-level. 
A search in Pubmed was done to find possible studies that support inclusion of the non-
significant variables. Factors that had shown significant effect on the dependent variable in 
earlier research were included independently of their level of statistical significance in this 
study. Intercorrelations between variables included in the models were checked in 
Spearman's correlation analyses.  
The assumptions of normality, linearity and homoscedasticity for the standardized 
residuals, and possible problems with outliers were checked by using histograms, P-P-
plots, scatterplots, collinearity diagnostics, list over residuals, and Cook's Distance.   
3.4.5. Chi-Square tests 
Eating an 'Obesogenic diet' 
The Chi-square test was conducted to see if pregnant women eating an 'obesogenic diet' 
were more likely to give birth to a macrosomic infant than other pregnant women. The 
'Yates Correction of Continuity' was used when constructing 2x2 tables, to compensate for 
the overestimate of the chi-square value in a 2x2 table. When the assumptions for Chi-
square test were violated, the Fisher's Exact Test was used instead. Relative Risk 
estimates (RR) were calculated for statistical significant test results. 
Low versus high 
I wanted to find out if pregnant women who are in the 4th quartile (highest) of the dietary 
variables were more likely to give birth to an infant weighing ≥4200 g, than pregnant 
women who were in the lower quartiles. The Chi-square test was also conducted to find 
possible significant differences between women in different dietary quartiles. 
3.4.6. Trend test/Linear-by-linear 
The Trend-test was applied to dietary variables in quartiles, because they are ordinal 
variables. This was done to search for trends across the ordered groups rather than just 
finding any difference between the groups. Trends in both the second and third trimester 
of pregnancy were investigated and the dietary variables divided in quartiles were the 
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same as those in the Chi-square-test conducted earlier. Relative Risk estimate (RR) were 
calculated for statistical significant test results. 
3.4.7. Logistic regression 
Analyses on dietary data from the second and third trimester were done separately, thus 
two different models were created to investigate the relationship with risk of macrosomia 
(birth weight ≥4200 g). 
Because the dietary variables are not assumed to have a linear relationship with birth 
weight, these were recoded into bionomic variables, comparing the 4th quartile with the 
other quartiles for each variable. Variables significant at the 0.10-level in univariate 
analyses, and at the 0.05-level after adjusting in complete model were included. Because 
of the limitations of the model, a maximum of eight independent variables could be 
included. Assumptions of non-multi-colinearity between independent variables in the model 
were checked in correlations analyses prior of making the final models. 
3.5. Ethics 
The Regional Ethic Committee has approved this study. It is conducted according to the 
Declaration of Helsinki.  A written informed consent was obtained from each participant 
and all subjects participated voluntarily (see Appendix). 
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4. Results 
4.1. Subject characteristics, birth outcomes and diet  
Maternal age ranged from 19 years to 42 years in the group of the 553 women. At the first 
medical visit (week 14-16) during pregnancy 42% of the subjects had a body mass index 
equal or higher than 25.0 kg/m2. There was a significant difference in both body weight 
and body mass index when comparing women giving birth to macrosomic infants weighing 
(≥4200 g) with women giving birth to infants weighing <4200 g (table 2).   
Few subjects, only 4%, reported smoking during pregnancy. Smoking habits were not 
related to birth outcomes in univariate nor multivariate analysis of this cohort. A total of 
99% of the women were married or lived in relationships. The majority, 84% of the women, 
were educated at university or college-level. None of these measures of socio-economic 
status were associated with birth weight (table 2). Mean birth weight for the study cohort 
was 3619 g (SD: 571). In total, the birth weight of 84 of the infants (15%) equalled 4200 g 
or higher (table 2). 
Table 2. Characteristics of 553 pregnant women and their new-borns from Oslo and its surroundings 
in STORK in 2001-2005. Comparison of between macrosomic and non-macrosomic babies.  
                                
Infant's weight at birth  
 
Continuous characteristics
 
All 
N=553 
<4200g 
N=469 
≥4200g 
N=84 
 
P-value 
Birth weight, infant (g) 3619(571)a    
Maternal age (years) 31(4)a 31(4)a 32(4)a  
Maternal weight, first visit (kg) 69(70-72)b 68(69-71)b 74(73-79)b <0.001 
Maternal height (cm)  169(168-169)b1 168(168-169)b2 170(168-171)b3  
     
Dichotomous characteristics 
(% of subjects) 
 
N=553 
 
N=469 
 
N=84 
 
Smoking during pregnancy N=22 (4%) N=20 (4,3%) N=2 (2,4%)  
Infant born pre-term  
(<37 weeks of gestation) 
 
N=30 (5,4%) 
 
N=30 (6,4%) 
 
N=0 (0%) 
 
0.015 
Married/living in a relationship N=547 (99%) N=464 (99%) N=83 (99%)  
Educated at college/university-level  N=467 (84%) N=398 (85%) N=69 (82%)  
BMI>25 kg/m2  N=222 (42%)1 N=176 (39%)2 N=46 (58%)3 0.002 
Parity (0) N=293 (53%) N=264 (56%) N=29 (35%) <0.001 
Gender (boy) N=295 (53%) N=237 (51%) N=58 (69%) 0.002 
a
 mean(SD) 
b 
median(95% CI) 
1 N=530 
2 N=450 
3 N=80 
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There were some significant differences at the 0.05-level when comparing the self-
reported food-intake in the second and week 30-32 of pregnancy. In week 30-32 the 
percentage of energy from protein was lower, saturated fat was higher, added sugars was 
higher, fiber was lower compared to consumption in week 14-16 of pregnancy (table 3). 
 
 
Table 3. Self-reported diet among pregnant women using a FFQ (NORKOST). Nutrient intakes in 
week 14-16 and week 30-32 are compared. 
  
In week 14-16, 85% ate too much saturated fat, 66% too little dietary fiber, 30% too much 
added sugar, and 42% too little omega-3 fatty acids compared to the recommended levels 
in NNR 2004(6). Their nutrient intake is less in accordance with the NNR 2004 in week 30-
32, when 87% ate too much saturated fat, 70% too little dietary fiber, and 31% too much 
added sugar (table 4). 
 
 
 
 
 
Mean SD Mediana Mean SD Mediana
Energy (kJ) 3472 15136 8611 2037 3674 17489 8669 2008
Protein (E%)1 10 24 16 2 9 24 15 2 <0.001
Total fat (E%)1 18 47 31 5 17 49 32 5
Saturated fat (E%)1 6 21 ..12.2.. 2 12 7 19  12.4. 2  12.4. 0.03
Monounsaturated fat (E%)1 6 16 10 2 5 18 10 2
Polyunsaturated fat (E%)1 3 14  6.5. 2  6.2. 3 14  6.4. 2  6.2.
Omega-6 fatty acids (E%)1 2 12  5.3. 2  5.0. 2 12  5.2. 2  5.0.
Omega-3 fatty acids (E%)1 0.4 ..2.4..  1.1. 0.4  1.1. 0.4 ..2.5..  1.1. 0.3  1.1.
Carbohydrates (E%)1 39 67 53 5 52 36 67 53 5 53
Added sugar (E%)1 0.5 32  8.3. 5  7.3. 0.3 38  9.0. 5  8.0. <0.001
Fiber (g) 6 60 24 8 23 9 55 24 7 23
Fiber (g/MJ) 0.9 6  2.8. 0.7  2.7. 1 6  2.7. 0.7  2.7. 0.03
1Percentage from total energy intake
P-value
aMedian presented for skewed data only
Week 30-32 of pregnancy (N=511)Week 14-16 of pregnancy (N=548)
 Min Max Min Max
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Table 4. Proportion of subjects in STORK not eating within the recommended limits (NNR 2004) 
 
Bread contributed with a mean of 20%, and thus the most, of the energy-intake among the 
pregnant women in STORK. Meat and meat products gave the most protein with a mean 
of 20%. Saturated fat was provided mostly by oil, margarine and butter (mean of 21%) and 
cheese (mean of 18%). A mean of 33% of all omega-3 fatty acids came from oil and 
margarine. Soft drinks with sugar contributed with a mean intake of 29% of all dietary 
added sugar, whereas sweets and chocolate contributed with 23% of the added sugar. 
Fiber was mostly provided by bread, with a mean contribution of 34% (table 5). 
 
Table 5. Type of food providing most energy and selected energy-providing nutrients in week 14-16 
of pregnancy, from a self-reported FFQ. N= 548. Mean values. Numbers in percentage. For the full 
list, see the Appendix.   
Energy Protein Saturated fat Omega-3 Added sugar Fiber
Bread 20 16  - 10  - 34
Cakes, cookies  -  - 5  - 6  - 
Cereals 9 9 4  -  - 11
Cheese 6 10 18  -  -  - 
Eggs  -  -  -  -  -  - 
Fish, seafoods 3 10  - 17  -  - 
Fruits and berries 10  -  -  - 15 23
Meat and meat products 9 20 17 7  -  - 
Milk, yoghurt, cream 11 16 14  - 17  - 
Oil, margarin, butter 8  - 21 33  -  - 
Potatoes  -  -  -  -  - 5
Soft drinks with sugar  -  -  -  - 29  - 
Sugar (refined granulated)  -  -  -  - 6  - 
Supplements  -  -  - 16  -  - 
Sweets, chocolate 4  - 6  - 23  - 
Vegetables 5 5  - 7  - 21
 - corresponding to less than 4 %
Week 14-16 of pregnancy Week 30-32 of pregnancy
% N % N
Low dietary fiber (<3 g/MJ/day) 66 362 70 359
High added sugars, (>10 E%/day) 30 163 31 160
Low in carbohydrates, (<50 E%) 29 159 28 143
High in carbohydrates, (>60 E%) 10 52 9 45
High in total fat,( >30 E%/day) 61 335 65 331
Higher in total fat,( >35 E%/day) 26 143 23 119
High in saturated fatty acids, (>10 E%/day) 85 468 87 445
High in PUFA (>10 E%/day) 4 23 3 16
Low in omega-3 fatty acids, (<1 E%/day) 42 227 41 207
Low in protein (<10 E%) 0 0  0.8. 4
High in protein (>20 E%/day)  2.7. 15  2.5. 13
N=548 N=511
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In week 14-16 of pregnancy women in STORK consumed an average of 596 g of mixed 
greens daily according to the self-reported FFQ. The mean mixed greens intake in week 
30-32 of pregnancy was lower, with a total of 557 g per day (table 6). The full list of food-
types and their contribution to different nutrients, energy and fiber in both second and third 
trimester is found in the Appendix. 
 
Table 6. Amounts consumed of selected foods in the week 14-16 and week 30-32 of pregnancy,
   from a self-reported FFQ 
 
 
4.2. Nutrition factors affecting the infant's birth weight 
4.2.1. Obesogenic diet compared to a non-obesogenic diet 
Subjects who ate a diet in which more than 10 E% of the energy came from added sugars 
in week 14-16 of pregnancy, gave birth to infants with a significant higher (p= 0.05) birth 
weight than those restricting their sugar intake to 10 E% or less in the same period. The 
mean birth weight of infants' whose mothers restricted the sugar intake to the 
recommended levels was 3588 g (SD 594), whereas a higher intake gave a mean birth 
weight of 3690 g (SD 506) (figure 2).  
There were no other significant results found at the 0.05-level in the second, or third 
trimester of pregnancy, when investigating whether pregnant women who ate an 
Week 14-16 of pregnancy Week 30-32 of pregnancy
N=548 N=511
Type of food mean intake/day, (g) mean intake/day, (g)
Fruits and berries 382 362
Milk, yoghurt, cream 382 409
Tea 235 200
Vegetables 214 195
Bread 161 157
Softdrinks with artificial sweeteners 128 153
Softdrinks with sugar 122 116
Meat and meat products 104 101
Coffee 69 89
Fish, seafoods 47 44
Cheese 33 31
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'obesogenic diet' gave birth to heavier infants than pregnant women who ate within the 
recommended levels stated in the NNR 2004 (6).   
 
Figure 2. Mean birth weight of infant (grams) and added sugar intake in week 14-16 of 
pregnancy of a total 548 subjects. Women with added sugar intake ≤10 E% gave birth to infants 
with a significantly lower birth weight than women with higher intakes of added sugar. The error bars 
represent 95% CI of the mean.   
 
 
 
 
 
 
 
4.2.2. Different levels of dietary intake 
Women with the highest consumption of omega-3 fatty acids in week 30-32 gave birth to 
lighter infants. Accordingly there was a significant difference (p=0.05) in birth weight 
between: infants whose mothers had an omega-3 intake corresponding to the 4th quartile 
(equal 1.3 E% or higher from omega-3 fatty acids, Mean=3556g, SD=553) in week 30-32, 
and infants whose mothers had lower intakes (Mean=3665g, SD=552) in week 30-32 
(figure 3). 
No other significant differences were found in infants' birth weight whose mothers' had 
different intakes (of energy, nutrients and fiber) during pregnancy corresponding to defined 
levels and quartiles. This non-significant result was evident in the analyses conducted both 
in week 14-16 and week 30-32 of pregnancy.  
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Figure 3. Mean birth weight of infant (grams) and omega-3 fatty acids intake in week 30-32 of 
pregnancy of a total 511 subjects. Women with omega-3 fatty acids intake in Q1, Q2 and Q3   
(<1.3 E%) gave birth to infants with a significantly higher birth weight than women with the highest 
intakes of omega-3 fatty acids (Q4 ≥1.3 E%). The error bars represent 95% CI of the mean. 
 
 
 
 
 
 
 
4.3. Nutrition factors contributing to a higher risk of 
macrosomia 
4.3.1. Obesogenic diet compared to a non-obesogenic diet 
The proportion of pregnant women who gave birth to a macrosomic infant (≥4200 g) and 
consumed an 'obesogenic diet' during the week 14-16 or week 30-32 is not significantly 
different from the proportion of pregnant women who gave birth to a macrosomic infant 
and eating a 'non-obesogenic diet' during week 14-16 or week 30-32.   
4.3.2. Different levels of dietary intake 
There was a significant linear trend (p=0.02) between level of protein intake in percentage 
of energy in week 14-16 of pregnancy and giving birth to a macrosomic infant (≥4200 g). 
The risk of delivering a macrosomic infant is lower when the percentage of protein in the 
pregnant woman's diet increases. The relative risk of giving birth to a macrosomic infant 
falls with 55.6% (CI: 76.5%, 15.9%) if the pregnant woman consumes higher levels of 
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protein (4th quartile: ≥17 E%) compared with lower levels (1st quartile: ≤ 14.3 E%) in week 
14-16 of pregnancy (Chi-square: p=0.009) (figure 4). 
In a logistic regression model for factors related to risk of macrosomia, protein 
consumption in week 14-16 was the only significant dietary factor at the 0.05-level when 
controlling for BMI category (25 kg/m2 or more in early pregnancy), parity, the infant's 
gender, gestational age and maternal birth weight. Pregnant women in the highest quartile 
of protein intake measured in percentage of total energy consumption (≥17 E% from 
protein) had an OR=0.5 (95% CI: 0.2, 0.9) of giving birth to a macrosomic infant compared 
to women in the lower quartiles (p=0.03) (table 7). 
No significant effect of the dietary variables on giving birth to a macrosomic infant (≥4200 
g) were found in week 14-16 or week 30-32 of pregnancy when comparing different levels 
of intakes, quartiles and trends. 
 
Figure 4. Protein intake in week 14-16 of pregnancy in different quartiles: 1st≤ 14.3 E% 
(reference group), 2nd>14.3 - 15.6 E%, 3rd>15.6 - 16.9 E% and 4th ≥17 E%, and RR for giving birth to 
a macrosomic infant (≥4200 g).  
 
 
 
 
 
 
 
 
*Significantly different from the 1st quartile (at the 0.05-level).  
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Table 7. Logistic regression model. Factors related to giving birth to a macrosomic infant (N=501) 
 
P-value OR
Lower Upper
Protein intake ≥17E% 
in week 14-16 of pregnancy1
BMI category ≥25 (kg/m2) 2 0.02 .1.9. .1.1. .3.3.
Parity ≥ 1 3 0.002 .2.4. .1.4. .4.1.
Gender4 0.003 .2.4. .1.3. .4.2.
Gestational age <0.001 .1.8. .1.4. .2.2.
Maternal birth weight (g) 0.006 1.001 1 1.001
3Multiparous women compared to primiparous women
4Gender of infant: Male compared to female (reference group)
1Protein intake ≥17E% (corresponding to the 4th quartile) in week 14-16 of pregnancy compared to lower intakes
2BMI ≥25 kg/m2 in week 14-16 of pregnancy compared to lower BMI values
95% CI for OR
0.03 0.5 0.2 0.9
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5. Discussion 
5.1. Study population 
5.1.1. Non-participation 
There are several reasons to believe that participants in STORK may differ from the non-
participants. Firstly, a study like STORK, that included four hospital visits, several 
questionnaires, anthropometrical measurements, blood samples and glucose tolerance 
tests, is time-consuming and invasive for the participants. Secondly, many pregnant 
women experience nausea and tiredness during pregnancy, which in turn means that 
participating may be found demanding. Thirdly, participants were attending antenatal 
controls more often than the normal population, they were also given an opportunity to 
attend three ultrasound scans, in contrast to only one ultrasound scan offered in the 
standard national antenatal care program (8).  Accordingly, the participants may have a 
higher education level than the non-participants, they may be more interested in science or 
more anxious about their pregnancy, or may be older, sicker or having other reasons to be 
interested in close follow up during pregnancy. There were only eight drop-outs, thus drop-
outs-analyses are not conducted, due to the scarce number. Besides, data from non-
participants are not available; hence it remains unclear to what extent the participants are 
significantly different from the non-participants.  
5.1.2. Comparing the STORK population to Norwegian pregnant  women 
Data from MBRN in 2006 (39), show that pregnant women and their infants are somewhat 
different from the STORK population. In Norway smoking is associated with a low socio-
economic status (74), and is consequently a relevant comparable indicator. The number of 
smokers among all pregnant women giving birth in Norway were 15.6% in the beginning of 
pregnancy (83.8% response rate of all 55 509 pregnancies), and 8.5% in the last trimester. 
In the Oslo-area the number of pregnant smokers were 6.4% in the beginning of 
pregnancy (39), in comparison to the STORK population in which the number of smokers 
was as low as 4%. This may indicate that the STORK population come from a higher 
socio-economic level than the mean of the general population in Norway and Oslo. 
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In 2006, according to the MBRN data (39), the mean age of women giving birth was 29.7 
years at a national level, and 30.8 years in Oslo, whereas it was 31 years in STORK. The 
mean birth weight was 3494 g at national level, 3435 g in Oslo and 3619 g in the STORK 
population. In total 41.5% of pregnant women in Norway and 51.3% in Oslo were 
primiparous in 2006, whereas in STORK 53% were expecting their first child. Overall, 
93.1% in Norway, 93.2% in Oslo and 99% of women in the STORK project lived in a 
relationship. When comparing these data, it is important to note that 23% of the Oslo-
population have a non-western background (75), whereas all the subjects in STORK are 
native Scandinavian. 
The women in STORK have also been compared to a corresponding native Scandinavian 
group of 151 women giving birth at Rikshospitalet-Radiumhospitalet medical centre who 
were non-participants in STORK, and a second corresponding group of 85 pregnant native 
Scandinavian women at Ullevål University Hospital. They were all found to be quite similar 
when comparing age, weight before pregnancy, height (76).  
These results show that the women in STORK may be different from the Norwegian 
population in total, but they seem to be more alike other pregnant women of Scandinavian 
heritage living in Oslo. Thus the results may be extrapolated to other pregnant native 
Scandinavian or Caucasian women from urban areas living in the western world.  
5.2. Methods 
5.2.1. Methods of dietary assessment 
In STORK, the food frequency questionnaire, NORKOST, was chosen as the best 
available way to collect dietary data from the participants. When studying the food and 
nutrient intake in large populations, food frequency questionnaires are considered an 
appropriate tool because they are cost-effective; they are relatively inexpensive and easy 
to use both for the participant and the administrator.  
It is possible that other dietary assessment methods would have provided a more accurate 
estimate of the food intake. A weighed diet record seems to reflect the true intake more 
accurate than the FFQ and 24-recall (77). However, even if the weighed diet record gives 
a better estimate of the nutrient intake of the participants, they require more of the 
participant than the FFQ. Because of the need to measure nutrient intake twice during 
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pregnancy, it was important to choose a questionnaire in STORK that would be most likely 
to be completed by as many participants as possible, in order to get the best possible data 
to study. Consequently, we believe the respond-rates are as good as we believe we could 
get with the available resources. 
Validation of the FFQ 
Several studies have evaluated this NORKOST questionnaire, and concluded that it 
measures energy and nutrient intake in an adequate way compared to other methods, as 
well as being suitable for Norwegian nutrition surveys (78-81). A FFQ designed especially 
and validated for pregnant women was not available when data collection started in 2002. 
Later the Norwegian Mother and Child Cohort Study designed such a questionnaire, which 
is being validated now (2007). This new FFQ has been analysed in analyses of correlation 
against NORKOST in a small sample of 86 women. The results show that energy intake 
correlates with 0.69 and protein correlates with 0.72 at the 0.01-level in the two different 
FFQs (82). These results indicate that NORKOST may be a suitable tool when measuring 
energy and macronutrients in a population of pregnant, native Scandinavian women.  
An evaluation of the instructions and use of the FFQ 
The FFQ used in STORK was originally designed to measure the mean intake the last six 
months or last year, whereas the participants in STORK were instructed to report what 
they ate at the time they completed the questionnaire. The study subjects completed two 
questionnaires within a time period of 14-18 weeks, corresponding to 3-4 months. This 
may have affected the reported intake. Accordingly, it is possible that the reported intake 
in week 30-32 has overlapped the actual intake in week 14-16, thus the differences in 
intake between early and late pregnancy may be less evident in the analyses than it is in 
reality.  
Under-reporting 
Under-reporting food intake is a well-known phenomenon in dietary surveys and is caused 
by a variety factors (83). Under-reporting can be divided in two subtypes: 'Under-eating' 
and 'under-registration'. When subjects 'under-eat', they eat less than they normally do 
due to the fact that they are conscious of what they are eating when reporting. When 
subjects are 'under-registering', they omit reporting what they actually are consuming. 
Energy intake (EI) divided by BMR will give an estimate whether or not subjects are having 
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an EI that is consistent with life over time. Under-reporters are subjects with values for 
EI:BMR <1.35, whereas <1.14 is not consistent with life (84).  
According to these cut-off levels, 47% of subjects in STORK under-reported in week 14-16 
and of these 24% had an EI:BMR <1.14. In week 30-32, 47% of subjects still under-
reported according to the <1.35 cut-off level, and 23% were <1.14. This is in accordance 
with a recent Swedish study that concluded that it is common for pregnant women to 
under-report their energy intake (85). This widespread under-reporting may conceal true 
effects between diet and maternal -and infant health risk, and must for that reason be 
taken into account when discussing the results. 
5.2.2. Birth weight as a method for predicting neonatal outcomes  
Birth weight cut-off levels are used to define macrosomia, and consequently infants at risk 
for adverse health outcomes. As suggested earlier: In addition to the more mechanical 
short-term consequences of macrosomia, like injuries to the infant and the mother during 
birth, macrosomic infants have been living in an over nourished fetal environment that 
have affected the metabolism, structure and physiology in a permanent way, and as a 
result increased their risk of disease (4;55;56;61-63).  
 
However, the question of whether birth weight is a good measurement and method for 
predicting neonatal outcomes or not, must be reviewed. The simple measurement of the 
newborn's weight cannot tell us anything about body composition and amount of fat-free-
mass in the infant. When discussing fetal macrosomia understood as fetal overweight with 
possible metabolic changes and long-term consequences, it is possible that a distinction 
between genetically large fetuses and those who are overweight should be made. Fetal 
macrosomia is a heterogeneous condition both in terms of definition (42-44), as well as 
when looking at the etiological factors. In some studies it is suggested that macrosomia 
should not be classified on the basis of birth weight and gestational age alone. Different 
mathematical formulas have been suggested to relate body fat to body weight, that consist 
of weight for height or some power function of height. The ponderal index is one 
suggestion, were weight (in kilograms) is divided by the length (in meters) cubed (41). This 
ponderal index has been proposed as a better way of classifying macrosomic infants, also 
because both a symmetric and an asymmetric subtype of macrosomia have been 
described, and may be classified with using this ponderal index (86).    
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On the other hand, a study from 2004 compared birth weight, ponderal index and BMI of 
9226 infants, to see which would predict admission to the neonatal intensive unit, or a 
prolonged hospitalization the best. With regards to these two short-term outcomes, birth 
weight was a better predictor than either BMI or ponderal Index (87). 
Yet it seems clear that birth weight has limitations and to improve the understanding of 
macrosomia, studies of body-composition will be needed. There are biophysical 
techniques available for this purpose: Total body electrical conductivity and dual energy X-
ray absorptiomentry (DEXA). However, these methods are time and resource demanding 
and accordingly mostly for use in scientific studies, not in clinical practice (41). In part two 
of the ongoing STORK study, DEXA is used on all infants. This will hopefully add more 
information about the macrosomic infant in terms of differentiating between the genetically 
large but lean infant and the morbid large infant with excessive fat tissue.  
 
5.2.3. The 'Obesogenic diet', An evaluation 
The definition 'obesogenic diet' was constructed to gather the nutritional factors at levels 
that were thought to contribute to a higher risk of macrosomia or have a positive effect on 
birth weight. The constructs of the definition are based on relevant findings in the literature 
and my own reflections of what may be possible relations between diet and high birth 
weight. 
High total energy was chosen because having a positive energy-balance, meaning a 
higher energy-intake than the total energy requirement, will lead to excessive weight in the 
mother, and possibly also in the fetus. Despite methodological limitations, energy-balance 
is a better measurement than total energy-intake itself, due to the fact that it was possible 
to correct for maternal height and body weight when calculating the energy-balance. 
Low dietary fiber was set at a level below the recommended level of fiber consumption in 
the New Nordic Recommendations from 2004 (NNR2004). There is a strong body of 
evidence that recommended levels of dietary fiber helps control body weight (6), and thus 
possible prevention of excessive fetal weight gain.  
High added sugars was set at a level above the maximum recommended level of added 
sugar intake in NNR2004 (6). There are studies showing that intake of sweetened soft 
drinks is correlated with overweight and obesity (88). Sweetened soft drinks have a very 
high content of added sugar with 100 E% coming from added sugar (7), thus added sugar 
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was thought to lead to maternal overweight and obesity. In addition, it is well known from 
diabetic pregnancies that there is a direct relationship between maternal blood glucose 
levels and size at birth (89), thus a diet that may elevate the maternal blood sugar in non-
diabetic women was thought to be of importance and have a possible positive effect on 
birth weight. 
High total fat was set at a level higher than what is recommended for overweight subjects 
who want to prevent additional weight gain (6). Fat contributes with more energy per gram 
than protein or carbohydrates (7), thus a diet high in total fat was thought to easily lead to 
excessive maternal weight gain and possible fetal weight gain. 
Low protein was set at a level that lies within the recommended level of protein intake (6). 
A level of protein intake of less than 10 E% would be below the recommended level. 
However, in the Norwegian population, the mean intake indicates that such low level is 
found among very few (90), thus the 'low protein' intake was defined to 15 E% or lower 
There is no consensus that moderate or high protein diets prevent overweight and obesity 
in adults, and it may seem as if the macronutrient composition of the diet is of little 
importance as long as the total energy intake is restricted (6;91). However a Cochrane 
review indicates that high protein diets during pregnancy may give lower birth weight (92), 
consequently this variable was included in the analyses. 
The chosen constructs of the 'obesogenic diet' can be criticized because of the limited 
evidence supporting associations with a higher birth weight or higher risk of macrosomia. 
However, these factors were to be proven right or wrong in this thesis, not beforehand.   
5.3. Interpretations of results 
5.3.1 Women not eating within the recommended levels 
Pregnant women are according to the NNR 2004 (6) supposed to eat a balanced healthy 
diet, similar to what is recommended to the normal population. The exceptions are higher 
energy intake, higher levels of essential fatty acids, and higher levels of micronutrients. 
The results from the analyses reveal that a large proportion of the women in STORK are 
not eating within these recommended levels stated in NNR 2004. A national dietary survey 
from 1997 (90), using the same FFQ as used in STORK, shows that non-pregnant 
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Norwegian women at the age of 20-29 and 30-39 have a mean intake of 20 and 21 g of 
dietary fiber/day respectively, 11.8 and 9.3 E% added sugar, 12.0 and 12.7 E% from 
saturated fat, and 5.3 and 5.6 PUFA (including both omega-3 and omega-6 fatty acids). It 
is not shown how large percentage of the studied group did not follow the recommended 
intakes. However, when looking at mean values in the STORK population, the mean fiber 
intake is higher, the added sugar intake is lower, saturated fat is at the same level, and 
intake of PUFA is higher than in the general female population from 1997 aged 20-39. This 
indicates that despite the fact that many pregnant women have an unfavourable diet, they 
seem to be eating healthier than women of fertile age in the Norwegian population. Yet, 
one must be aware of the time difference between 1997 and 2002-2005, which may 
change the picture.  
Dietary data from late 1990 from an urban pregnant Norwegian population exist (66;67). 
Pregnant women had a median energy intake of 8.2 MJ, saturated fat intake of 12 E%, 
PUFA intake of 5 E%, and 0.9 E% intake from omega-3 fatty acids. Additionally the intake 
was 30 E% from total fat, 8 E% from added sugar, 16 E% from protein and 21 g/day from 
dietary fiber. In conclusion, reported energy, total fat and saturated fat, PUFA and dietary 
fiber intake is slightly higher whereas MUFA and added sugar intake is marginally lower in 
the STORK population compared to data from the 1990-results.  
Results from The Cardiovascular Risk Reduction diet in Pregnancy study (CARRDIP) 
showed beneficial effects, in terms of reduced risk of preterm birth, among women eating 
a diet low in saturated fat and cholesterol during pregnancy (93). Clausen et al imply that a 
maternal diet with high levels of sucrose, energy and PUFA increase the risk of 
preeclampsia (94). Such results substantiate the importance of influencing the pregnant 
population in order to reduce the large proportion of women eating a diet not within the 
recommended levels. 
 
5.3.2. Knowing the contents of foods 
Health workers working with pregnant women should be more aware of what food items 
are contributing to excess of the beneficial and less healthy nutrients to be able to guide 
the pregnant women.  
In the STORK population, added sugar and saturated fat intake should be decreased 
whereas omega-3 fatty acids and dietary fiber intake should be increased. Focus in clinical 
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practice should be on food items, not on nutrients alone. In the STORK population, 
avoidance or a decrease in consumption of soft drinks, sweets and chocolates, butter, 
margarine, cheese, meat and meat products, milk, yoghurt and cream would be beneficial. 
In addition an increase in consumption of drinking water, fat reduced milk and diary 
products, soft vegetable oil based margarine and lean meat products, fish and seafood, 
and supplements such as 'Tran' (Cod liver oil), mixed greens would be advisable. 
 
5.3.3. Maternal intake of protein and associations with birthweight 
All women in the STORK study have good protein intakes at levels thought to be sufficient 
to meet the needs of the mother and fetus. WHO recommends an intake of 0.75 g high-
quality protein per kg body weight per day, which corresponds to less than 8-10 E%, 
whereas the Nordic recommendations, based on estimated requirements and the Nordic 
dietary habits, is 10-20 E%, the same level as for the general population (6) Stated thus, 
the comparison in this thesis have been done between women eating moderate amounts 
of protein and those eating an excess amount of protein. 
Analyses in this thesis show that a high maternal intake of protein in week 14-16, defined 
as a diet with 17 E% or above from protein, reduces the risk of having a macrosomic 
infant. Similar results are seen in a study of 1040 mother-infant pairs from Australia, in 
which an increase of absolute protein intake/day was associated with a reduction in birth 
weight. In addition, higher protein intake in the third trimester was associated with a 
reduced ponderal index among large birth weight infants but not low birth weight infants 
(95). Kramer and Kakuma have assessed the effect of high protein supplement in 
maternal diet during pregnancy, and found a non-significant reduction in birth size (92). A 
review article from 2006 refers to experiments in rats, that may support very high maternal 
protein intake during pregnancy restrict fetal growth compared to adequate, but not low, 
levels of protein intake (96). All this indicates that high maternal protein intake may affect 
birth weight negatively compared to adequate intakes, and that protein intake may affect 
the body composition of the infant.         
   
One of the main focuses of the STORK study was to find factors contributing to a higher 
risk of macrosomia, and then to do something about these identified risk factors in clinical 
practice. It seems as if a high intake of protein may be favourable to reduce the risk of 
macrosomia. Should medical personnel and nutritionists working with pregnant women 
advice them to eat such a diet? Firstly, the results must be applied with caution until further 
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studies may confirm the same findings. Secondly, a review article from 2003 Kramer and 
Kakuma found that high-protein diets during pregnancy may be harmful for the infant (92). 
Furthermore, a study from Scotland has assessed the effect of a maternal high protein 
diet. A higher systolic blood pressure were found among the now adult infants of women 
who had a markedly increased their protein intake by eating more meat, in the second half 
of pregnancy (97). In addition, a study of 251 subjects, whose women had been advised to 
eat 0.45 kg of red meat daily during pregnancy and avoid carbohydrate-rich foods, cortisol 
concentrations increased 5.4% per portion of maternal meat/fish consumption per day, 
decreased 3.3% per portion of maternal green vegetable consumption per week. This 
indicates that an unbalanced maternal diet may also increase maternal cortisol levels, 
exposing the fetus to excess cortisol (98) which may be unfavourable for the fetus. 
In conclusion, it seems clear that in despite of possible favourable effects on birth weight, 
it is not safe and ethically responsible to promote high-protein diets to pregnant women. 
The general consumption of protein in the STORK population and in the Norwegian 
population is high; in 1997 women in the age group 20-39 had a protein intake of around 
15 E% (90), and the consumption of meat has increased since and is higher than ever 
registered before 2006 (99). Considering these levels and possible harmful effects of a 
high protein diet during pregnancy, it may be favourable to guide pregnant women to eat 
more mixed greens prior to meat. Meat products and cheese contribute with 29-30% of 
total protein intake during pregnancy, in addition to 32-35% of the already too high intake 
of saturated fat. 
5.3.4. Maternal intake of added sugar and assosiations with birthweight 
Concerning the literature, I was not able to find other studies were the effect of different 
maternal intakes of added sugar on the infant's birth weight in a non-diabetic population 
were assessed.  
Intake in the STORK population of added sugar varied largely. Many of the pregnant 
women in STORK did not manage to limit their intake to the recommended levels. More 
importantly, most of the women eating more than recommended, did not exceed 20 E% 
from added sugar. Only one subject had an intake over 30 E%. Consequently, even 
though too many ate too much sugar, few had very extreme intakes. Lack of significant 
results in the multivariate analyses may be explained by the fact that the true physiological 
effect may work in a dose-response manner.  
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However, there is now ample evidence that a diet high in added sugar is unhealthy even 
when not pregnant, contributing only with 'empty-calories' which dilute the quality of the 
diet and increase the risk of getting dental caries (100). In addition it is well proved that a 
consumption of sugar-containing soft drinks is positively correlated with overweight and 
obesity (88):  When pregnant this may increase the risk of stillbirth and neonatal death 
(10;12) and additional adverse health outcomes such as a higher risk of macrosomia 
(10;15-18). Accordingly, there is sufficient basis to assert that a reduced intake of added 
sugars both in the non-pregnant and pregnant state is recommendable. 
5.3.5. Maternal intake of omega-3 fatty acids and assosiations with 
birthweight 
A meta-analysis from 2006 examined the effect of omega-3 fatty acids on maternal health 
and fetal growth and development. They concluded that omega-3 fatty acids 
supplementation during pregnancy may increase pregnancy duration and head 
circumference, but that the mean effect size was thought to be small (101).  
Another review-article from 2006 found no clear consensus regarding the effects of 
omega-3 fatty acids during pregnancy or the early postpartum period on duration of 
gestation and infant size at birth, preeclampsia, depression, infant visual function and 
neurodevelopment. The available data suggest only a modest effect of omega-3 fatty 
acids on increasing gestational duration and possibly enhancing infant neurodevelopment 
(102). 
The results of the univariate analyses in this thesis show that the women that consumed 
the highest amounts of omega-3 fatty acids (corresponding to 1,3 E% from omega-3 fatty 
acids or higher) in late pregnancy gave birth to infants with a mean birth weight of 109 g 
lighter than women with a lower omega-3 fatty acids intake. This means that women with 
the lowest intake of omega-3 fatty acids gave birth to heavier infants. When controlling for 
other dietary factors and other factors, the effect was no longer significant. It is possible 
that these findings reflects that women with high intakes of omega-3 fatty acids have a 
lower BMI, which alone has a significant negative effect on birth weight.   
After revising the previous mentioned review article, meta-analysis, and my own findings, 
the effect of omega-3 fatty acids on birth weight remains unclear. Data from randomised, 
clinical, double blind trials (RCT) are needed to examine the true effect. Yet, after revising 
the literature there is no need to question that these omega-3 fatty acids have beneficial 
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health effects for mother and fetus. A study of Helland et al. from 2003 (103) confirms this 
by showing that children with high omega-3 fatty acids status have improved IQ at the age 
of 4 years compared to children with lower levels. However, it is important to note that 
despite omega-3 fatty acids are beneficial, too high levels have shown adverse effects, 
such as higher risk of preeclampsia in pregnant women with consumption of >7.5 E% from 
PUFA compared to lower intakes (94). Consequently, a balance between low and high 
intakes seems optimal. 
5.3.6. Diluted effects - an explanation of the absent effects 
The significant effects of the maternal intake of added sugar and omega-3 fatty acids on 
birth weight are not very strong. In addition, no other factors from the 'obesogenic diet' 
than added sugar had a significant effect on birth weight, nor did it increase the risk of 
delivering a macrosomic infant. Birth weight is, as shown in the statistical analyses, 
influenced by multiple factors, such as the infant's gender, gestational age, maternal BMI 
among others. Thus, the effects of these nutritional variables seem to be diluted by the 
other determinants that affect birth weight. In STORK the number of participants are 
relatively large (N=553), however, only 84 infants had a birth weight ≥4200 g, which is not 
overwhelming. Also, if the actual effects of added sugar and omega-3 fatty acids and 
possible others components in the 'obesogenic diet' are small enough, it is not possible to 
detect them properly. Therefore it is important to remember that these nutritional variables 
may be dose-dependent and extreme diets, for example a very high intake of added 
sugar, may have physiological consequences for mother and infant, as indicated by the 
small effect in the univariate analysis. 
5.4. BMI and physical fitness 
According to the WHO's body weight categories (19), 42% of the subjects in STORK were 
overweight or obese at the first medical visit (week 14-16). Even though BMI is not 
designed for pregnant women, it was calculated from the body weight at this first visit, 
which was early in pregnancy. Unfortunately, very few studies have examined the weight 
gain pattern in the first part of a normal singleton pregnancy. However, Clapp et al. 
evaluated weight gain during the first 15 weeks in detail from before conception. The mean 
weight gain at week 7 was 2 kg and 4.3 kg at week 15 (24). It is well established that 
people under-report their self-reported weight and BMI (104), therefore it is not reliable and 
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often not possible to obtain from all participants. Thus, the weight measured at the first 
visit was valued to be the better choice, despite the problems with using a body weight in 
week 14-16 of pregnancy to calculate the BMI. 
There exists accumulating convincing data, referred to earlier, which describes the 
adverse effects of overweight and obesity on pregnancy outcome with increased risk of 
macrosomia among their infants (10;15-18). In addition, the assessment of the physical 
activity level among women from the STORK-population, revealed a low activity level 
during pregnancy (34), which may increase the risk of macrosomia because physical 
aerobic activity is shown as important to keep birth weight within the normal range (28).  
The importance of physical activity, overweight and obesity on mortality and morbidity has 
been discussed in several studies, and it now seems evident that it is healthier to be 
physical active with a normal body weight, than inactive in general. More specifically, 
physical fit and overweight or obese individuals actually have lower morbidity and mortality 
than normal weight individuals who are sedentary (105;106).    
  
Preventing overweight and obesity and increase the physical fitness in the entire 
population, including women becoming pregnant, appears to be the optimal strategy to 
reduce mortality and morbidity, including the risk of macrosomia. However, when meeting 
pregnant women in clinical practice both excessive weight and inactivity are often already 
established, as we have seen among the women in STORK. As it is advisable to gain 
weight during pregnancy (24), women with excessive weight in early pregnancy should 
instead be advised to increase their activity level. Thus, despite of already existing 
recommendations for physical activity during pregnancy (8), too many seem to remain 
inactive, thus even more focus on physical activity before, during and after pregnancy is 
possibly needed. Pregnant women will most likely benefit from being encouraged to be 
active by receiving information about the positive effects of physical activity, types of 
activities they can do and at what level. 
5.5. Future directions 
The importance of an adequate diet and physical activity seems evident, and active weight 
control before and during pregnacy and physical activity in relation to the overall maternal 
and infant's health outcomes is described previously. However, the importance of life style 
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factors, including diet, in order to reduce the risk of macrosomia needs to be confirmed 
and explored further in detail.  
A follow up study of women before and during pregnancy to assess the effect of the pre-
pregnant nutritional- and fitness-state and body weight on the infant, would be ideal. In 
addition, future studies focusing on the diet and life style factors' effect on body 
composition of the macrosomic infants, and not only birth weight, are also highly relevant.  
A multi centre study with participants from all over Norway, including different ethnic 
groups covering both urban and rural areas would be better than this limited study of an 
urban population of women of Scandinavian heritage. This could provide a sample with 
larger differences in dietary intakes, level of physical activity and body composition. More 
extreme values may give clearer results.  
Despite the lack of scientific evidence, pregnant women are generally believed to be more 
open to new health information and changes than in the non-pregnant state. In addition, it 
is well established that children's food preferences and intake patterns are a clear 
reflection of the food they are exposed to in their family and close environment (107). 
Accordingly, dietary advice given to pregnant women may have positive health effects 
beyond her personal health as well as for the health of the fetus: It may also in the long 
run produce a change in her children and family's dietary habits. 
 
A great effect may come from promoting the already existing recommendations. Thus, the 
question of how to influence pregnant women to change their diet and life style should be 
addressed. Clinical nutritionists and other health workers should guide pregnant women, in 
how to achieve a healthier life style. However, it is likely that giving information to pregnant 
women is not enough. Well-designed interventions and studies of how to implement the 
existing recommendations are most likely needed. 
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6. Conclusion   
The prevalence of macrosomia is high in the Nordic countries, including Norway. Dietary 
factors seem to have a small, but not insignificant effect on the prevalence of overweight 
infants. Added sugar and omega-3 fatty acids intake have a significant effect on birth 
weight in univariate analyses, and high intakes of protein have a significantly preventive 
effect on the risk of delivering a macrosomic infant, also when controlling for other 
variables affecting birth weight. However, the effects of high protein diets during 
pregnancy have shown adverse health effects, and should not be promoted to pregnant 
women.    
Too many pregnant women eat an unbalanced diet that is not within the recommended 
guidelines. In addition, because of an inadequate diet combined with a sedentary lifestyle 
the prevalence of overweight in the pregnant population is high. Added sugars from soft 
drinks, sweets and chocolates and saturated fat from butter, cheese and minced meat and 
meat products contribute strongly to an unhealthy maternal diet.  
Consequently, a balanced diet within the present recommended levels, rich in mixed 
greens, whole grain cereals, fat reduced diary products, fish, and lean meat should be 
consumed, whereas soft drinks, sweets, chocolates, butter, cheese and minced meat and 
meat products should be limited during pregnancy. Extra attention should be given to 
those with a BMI not within the normal range and/or inactive subjects.  
Knowledge of how to advice and reach out to the pregnant population with the right 
information is a challenge, and must be focused on. More research is needed to confirm 
previous findings or add new information, so we can tailor advice to pregnant women at 
risk of delivering a macrosomic infant and thus prevent negative health outcomes. 
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8.1. Written consent from study subjects 
 
 
___________________________________________________________________________ 
___________________________________________________________________________ 
 
 Kvinneklinikken 
 Postadresse: 
0027 OSLO 
 
Besøksadresse: 
Sognsvannsv. 20 
 
Sentralbord:  
23 07 00 00 
Dir. linje:  
23 07 26 30/40 
Telefaks: 23 07 
Deres ref:  
Vår ref:  
Dato:  
 Org.nr.  
NO 970 897 771 
 
Til deg som er gravid og har fødeplass på Rikshospitalet 
 
 
Forespørsel om å delta i STORK-prosjektet 
(maternelt metabolsk syndrom, store barn og svangerskapskomplikasjoner) 
 
 
Stork-prosjektet søker å finne svar på hvorfor forekomsten av store barn er økende.  Fra 1990 til 1999 har 
andelen av barn med fødselsvekt over 4kg økt fra 16% til vel 20%.  Dette er en uheldig utvikling. Det er kjent 
at store barn kan medføre økt risiko for mor og barn under fødselen.   
Bakgrunnen for undersøkelsen er at vi ønsker å vite mer om hvorfor stadig flere kvinner føder store 
barn.  Det vil gi  mulighet til å identifisere kvinner som har økt risiko for å føde stort barn tidlig i 
svangerskapet, og utvikle støttetiltak for å motvirke denne utviklingen. 
Det finnes i dag ikke noe entydig svar på hvorfor det nå fødes flere store barn.  Hos noen er det genetisk 
bestemt.  Andre faktorer som også trolig påvirker fosterets vekst, er kvinnens fysiske aktivitet, type og mengde 
mat hun spiser og omsetningen av sukker i blodet.  
Ved å delta i undersøkelsen vil du bli fulgt opp av en fast jordmor som er prosjektleder her på 
Kvinneklinikken. 
Alle undersøkelsene er gratis, og du er forsikret på vanlig måte gjennom pasientskadeordningen. 
 
Undersøkelsen er kun ute etter å samle informasjon og vil ikke ha noen påvirkning på svangerskapet eller 
barnet ditt. 
 
 
Det er helt frivillig å bli med i undersøkelsen.  Selv om du har begynt, kan du når som helst og uten grunn 
trekke deg.  Dine data vil da bli slettet og ikke brukt i undersøkelsen.   
 
 
 
Undersøkelsene: 
 
Hvis du velger å delta, vil det bety fire kontroller på Rikshospitalet i løpet av svangerskapet.  Noen av disse vil 
kunne være i stedet for kontroller hos egen lege / jordmor. 
 
Hver gang møter du fastende, det betyr at du ikke skal spise eller drikke etter klokka 24.00.  Du får litt vann 
når du kommer. 
 
1. gang ved ca. 14-16 ukers svangerskapsvarighet  
 Kostholdsskjema som du har fått i posten skal leveres 
 Fastende blodsukkerbelastning. Du får drikke 75 g. druesukker.  Deretter tas det blodprøve fire ganger 
(hver ½-time)  for å måle hvordan kroppen reagerer på en viss mengde sukker. Vi setter inn en  
veneflon (et tynt plastrør) i en blodåre på armen, slik at det bare blir ett stikk. Prøven  tar litt over to 
timer, så det er lurt å ta med lesestoff og evt. en matpakke til å spise like etterpå.  Svaret vil foreligge 
med en gang, og du vil få vite resultatet. 
 
2. gang ved 22-24 uker.  
 Det blir tatt blodprøve til nedfrysing.  Det tar ca. 15 minutter. 
 Ultralyd av barnet for å måle vekst og trivsel.  Ultralydundersøkelsen vil også måle 
blodgjennomstrømningen i navlesnor og til livmoren.  Dette gir oss kunnskap om fosterets trivsel. 
 
3. gang ved 30-32 uker- 
 Sukkerbelastning som første gang, pluss 
 ultralyd som andre gang 
 nytt kostholdsskjema 
 
4. gang ved 36-38 uker 
 Blodprøver som andre gang, pluss 
 ultralyd som tidligere 
 fysisk aktivitetsskjema 
 
Det vil hver gang tas blodprøver som skal fryses ned.  Disse prøvene vil bli analysert først etter at hele 
prosjektet er gjennomført.   
 
 
 
 
Resultatene av undersøkelsen vil bli offentliggjort i godkjente tidsskrifter. 
 
Studien er vurdert av datatilsynet og regional etisk komite. 
 
 
 
 
Med vennlig hilsen 
 
 
………………….. 
Nanna Voldner 
jordmor / stipendiat 
 
 
 
 
  
 
 
 
 
Hvis du ønsker å være med i prosjektet er det fint hvis du så raskt som mulig gir 
en tilbakemelding til Kvinneklinikken. 
 
Du kan ringe til sekretær Tone Hassel 23 07 29 27 eller mobil 93 02 22 54 og si 
at du skal være med i STORK-prosjektet og du kan få time over telefon. 
 
Du kan også sende en e-post til tone.hassel@rikshospitalet.no 
og få time tilbake på mail. 
 
Spørsmål kan rettes til Nanna Voldner tlf: 23 07 29 26, mobil 99 73 82 90  
eller på mail. nanna.voldner@rikshospitalet.no 
 
 
 
 
 
 
 
Jeg har mottatt skriftlig informasjon om denne undersøkelsen og samtykker i å delta. 
 
 
________               ____________________________________________________ 
Dato                         Underskrift 
 
 
Jordmors erklæring: 
 
Jeg bekrefter at kvinnen har fått skriftlig og muntlig informasjon om hva det innebærer å delta 
i prosjektet. 
 
________                _____________________________________________________ 
Dato                           Underskrift (jordmor Nanna Voldner) 
 
___________________________________________________________________________ 
___________________________________________________________________________ 
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8.2. Ethical approvment of STORK 
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8.3. Food Frequency Questionnaire (NORKOST) 
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8.4. Food items providing energy, energy-giving nutrients and fiber  
8.4.1. In week 14-16 
8.4.2.  In week 30-32 
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